Pregled bibliografske jedinice broj: 1115870
A comprehensive approach to compatibility testing using chromatographic, thermal and spectroscopic techniques: evaluation of potential for a monolayer fixed-dose combination of 6-mercaptopurine and folic acid
A comprehensive approach to compatibility testing using chromatographic, thermal and spectroscopic techniques: evaluation of potential for a monolayer fixed-dose combination of 6-mercaptopurine and folic acid // Pharmaceuticals, 14 (2021), 3; 274, 16 doi:10.3390/ph14030274 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1115870 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
A comprehensive approach to compatibility testing using chromatographic, thermal and spectroscopic techniques: evaluation of potential for a monolayer fixed-dose combination of 6-mercaptopurine and folic acid
Autori
Brusač, Edvin ; Jeličić, Mario-Livio ; Cvetnić, Matija ; Amidžić Klarić, Daniela ; Nigović, Biljana ; Mornar, Ana
Izvornik
Pharmaceuticals (1424-8247) 14
(2021), 3;
274, 16
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
6-mercaptopurine ; folic acid ; compatibility testing ; inflammatory bowel disease ; forced degradation study
Sažetak
In this work, a systematical compatibility investigation of 6-mercaptopurine and folic acid, two commonly used medications in the treatment of inflammatory bowel disease, for the needs of a fixed-dose combination development strategy is shown. Various techniques and approaches, such as differential scanning calorimetry, isothermal stress testing, attenuated total reflectance-Fourier- transform infrared spectroscopy, dissolution medium stability and forced degradation studies, were used to elucidate the possible interactions from different aspects. The results predominantly point to the absence of physicochemical interactions between the examined substances in a variety of possible conditions. However, the forced degradation of the blend of substances and excipients in basic conditions showed a drastic degradation of 6- mercaptopurine, signifying that attention needs to be directed to the careful selection of the excipients for the formulation. To sum up, our findings indicate that a fixed-dose combination of 6-mercaptopurine and folic acid could be produced using one formulation blend, immensely simplifying its manufacture.
Izvorni jezik
Engleski
Znanstvena područja
Kemija, Farmacija
POVEZANOST RADA
Projekti:
UIP-2017-05-3949 - Razvoj naprednih analitičkih metoda za lijekove i biološki aktivne tvari u liječenju upalnih bolesti crijeva (IBDAnalytics) (Mornar Turk, Ana, HRZZ - 2017-05) ( CroRIS)
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Fakultet kemijskog inženjerstva i tehnologije, Zagreb
Profili:
Ana Mornar Turk
(autor)
Daniela Amidžić Klarić
(autor)
Matija Cvetnić
(autor)
Mario-Livio Jeličić
(autor)
Edvin Brusač
(autor)
Biljana Nigović
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- CA Search (Chemical Abstracts)